Hemiparkinsonism-somatic hemiatrophy syndrome.
Identifieur interne : 001461 ( PubMed/Checkpoint ); précédent : 001460; suivant : 001462Hemiparkinsonism-somatic hemiatrophy syndrome.
Auteurs : Mary Jenkins [Canada] ; Dan Mendonca ; Andrew Parrent ; Mandar S. JogSource :
- The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques [ 0317-1671 ] ; 2002.
English descriptors
- KwdEn :
- Adult, Electric Stimulation Therapy, Facial Hemiatrophy (pathology), Female, Growth Disorders, Humans, Musculoskeletal Abnormalities (pathology), Musculoskeletal Abnormalities (physiopathology), Parkinson Disease (physiopathology), Parkinson Disease (therapy), Subthalamic Nucleus (pathology), Subthalamic Nucleus (physiopathology), Syndrome, Tremor (etiology), Tremor (physiopathology), Tremor (therapy).
- MESH :
- etiology : Tremor.
- pathology : Facial Hemiatrophy, Musculoskeletal Abnormalities, Subthalamic Nucleus.
- physiopathology : Musculoskeletal Abnormalities, Parkinson Disease, Subthalamic Nucleus, Tremor.
- therapy : Parkinson Disease, Tremor.
- Adult, Electric Stimulation Therapy, Female, Growth Disorders, Humans, Syndrome.
Abstract
This paper highlights the hemiparkinsonism-hemiatrophy (HPHA) syndrome as a unique presentation of the parkinsonian state. Clinically relevant diagnostic and treatment aspects are reviewed.
PubMed: 12035843
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:12035843Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Hemiparkinsonism-somatic hemiatrophy syndrome.</title><author><name sortKey="Jenkins, Mary" sort="Jenkins, Mary" uniqKey="Jenkins M" first="Mary" last="Jenkins">Mary Jenkins</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Neurological Sciences, London Health Sciences Centre, ON, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Clinical Neurological Sciences, London Health Sciences Centre, ON</wicri:regionArea><wicri:noRegion>ON</wicri:noRegion></affiliation></author><author><name sortKey="Mendonca, Dan" sort="Mendonca, Dan" uniqKey="Mendonca D" first="Dan" last="Mendonca">Dan Mendonca</name></author><author><name sortKey="Parrent, Andrew" sort="Parrent, Andrew" uniqKey="Parrent A" first="Andrew" last="Parrent">Andrew Parrent</name></author><author><name sortKey="Jog, Mandar S" sort="Jog, Mandar S" uniqKey="Jog M" first="Mandar S" last="Jog">Mandar S. Jog</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2002">2002</date><idno type="RBID">pubmed:12035843</idno><idno type="pmid">12035843</idno><idno type="wicri:Area/PubMed/Corpus">001513</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001513</idno><idno type="wicri:Area/PubMed/Curation">001513</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001513</idno><idno type="wicri:Area/PubMed/Checkpoint">001513</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001513</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Hemiparkinsonism-somatic hemiatrophy syndrome.</title><author><name sortKey="Jenkins, Mary" sort="Jenkins, Mary" uniqKey="Jenkins M" first="Mary" last="Jenkins">Mary Jenkins</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Neurological Sciences, London Health Sciences Centre, ON, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Clinical Neurological Sciences, London Health Sciences Centre, ON</wicri:regionArea><wicri:noRegion>ON</wicri:noRegion></affiliation></author><author><name sortKey="Mendonca, Dan" sort="Mendonca, Dan" uniqKey="Mendonca D" first="Dan" last="Mendonca">Dan Mendonca</name></author><author><name sortKey="Parrent, Andrew" sort="Parrent, Andrew" uniqKey="Parrent A" first="Andrew" last="Parrent">Andrew Parrent</name></author><author><name sortKey="Jog, Mandar S" sort="Jog, Mandar S" uniqKey="Jog M" first="Mandar S" last="Jog">Mandar S. Jog</name></author></analytic><series><title level="j">The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques</title><idno type="ISSN">0317-1671</idno><imprint><date when="2002" type="published">2002</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Electric Stimulation Therapy</term><term>Facial Hemiatrophy (pathology)</term><term>Female</term><term>Growth Disorders</term><term>Humans</term><term>Musculoskeletal Abnormalities (pathology)</term><term>Musculoskeletal Abnormalities (physiopathology)</term><term>Parkinson Disease (physiopathology)</term><term>Parkinson Disease (therapy)</term><term>Subthalamic Nucleus (pathology)</term><term>Subthalamic Nucleus (physiopathology)</term><term>Syndrome</term><term>Tremor (etiology)</term><term>Tremor (physiopathology)</term><term>Tremor (therapy)</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Tremor</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Facial Hemiatrophy</term><term>Musculoskeletal Abnormalities</term><term>Subthalamic Nucleus</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Musculoskeletal Abnormalities</term><term>Parkinson Disease</term><term>Subthalamic Nucleus</term><term>Tremor</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Parkinson Disease</term><term>Tremor</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Electric Stimulation Therapy</term><term>Female</term><term>Growth Disorders</term><term>Humans</term><term>Syndrome</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This paper highlights the hemiparkinsonism-hemiatrophy (HPHA) syndrome as a unique presentation of the parkinsonian state. Clinically relevant diagnostic and treatment aspects are reviewed.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">12035843</PMID><DateCreated><Year>2002</Year><Month>05</Month><Day>30</Day></DateCreated><DateCompleted><Year>2002</Year><Month>11</Month><Day>08</Day></DateCompleted><DateRevised><Year>2004</Year><Month>11</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0317-1671</ISSN><JournalIssue CitedMedium="Print"><Volume>29</Volume><Issue>2</Issue><PubDate><Year>2002</Year><Month>May</Month></PubDate></JournalIssue><Title>The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques</Title><ISOAbbreviation>Can J Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Hemiparkinsonism-somatic hemiatrophy syndrome.</ArticleTitle><Pagination><MedlinePgn>184-7</MedlinePgn></Pagination><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">This paper highlights the hemiparkinsonism-hemiatrophy (HPHA) syndrome as a unique presentation of the parkinsonian state. Clinically relevant diagnostic and treatment aspects are reviewed.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">We report a case of HPHA, in a 21-year-old, otherwise healthy, woman. Clinical and radiographic features of our case are presented. We also review the current literature on the clinical, radiological and pathophysiological mechanisms of HPHA.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In our case, despite the lack of benefit from anticholinergics and dopamine agonists (the patient declined treatment with levodopa), the patient showed a dramatic improvement with subthalamic nucleus stimulator (STN) implantation. There are no reported cases of use of STN stimulator in HPHA.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Hemiparkinsonism-hemiatrophy is a distinct entity that may be clinically and pathogenetically different from idiopathic Parkinson's disease; hence, HPHA needs to be considered as a possible syndrome in patients that have persistent unilateral parkinsonism. As medications are reported to be unhelpful in HPHA cases, early surgical intervention may be an option, such as in our case.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jenkins</LastName><ForeName>Mary</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Clinical Neurological Sciences, London Health Sciences Centre, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mendonca</LastName><ForeName>Dan</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Parrent</LastName><ForeName>Andrew</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Jog</LastName><ForeName>Mandar S</ForeName><Initials>MS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Can J Neurol Sci</MedlineTA><NlmUniqueID>0415227</NlmUniqueID><ISSNLinking>0317-1671</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004599" MajorTopicYN="Y">Electric Stimulation Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005150" MajorTopicYN="N">Facial Hemiatrophy</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006130" MajorTopicYN="N">Growth Disorders</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009139" MajorTopicYN="N">Musculoskeletal Abnormalities</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020531" MajorTopicYN="N">Subthalamic Nucleus</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014202" MajorTopicYN="N">Tremor</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2002</Year><Month>5</Month><Day>31</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2002</Year><Month>11</Month><Day>26</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2002</Year><Month>5</Month><Day>31</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">12035843</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Canada</li></country></list><tree><noCountry><name sortKey="Jog, Mandar S" sort="Jog, Mandar S" uniqKey="Jog M" first="Mandar S" last="Jog">Mandar S. Jog</name><name sortKey="Mendonca, Dan" sort="Mendonca, Dan" uniqKey="Mendonca D" first="Dan" last="Mendonca">Dan Mendonca</name><name sortKey="Parrent, Andrew" sort="Parrent, Andrew" uniqKey="Parrent A" first="Andrew" last="Parrent">Andrew Parrent</name></noCountry><country name="Canada"><noRegion><name sortKey="Jenkins, Mary" sort="Jenkins, Mary" uniqKey="Jenkins M" first="Mary" last="Jenkins">Mary Jenkins</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001461 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 001461 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:12035843
|texte= Hemiparkinsonism-somatic hemiatrophy syndrome.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:12035843" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |